一例快速进展性呼吸不良和扩散性肺病变的情况
Shixuan Wang1, Jiping Liao1, Kunyao Yu1
1Department of Respiratory and Critical Care Medicine, Peking University First Hospital, Beijing, China.
Chest
|December 11, 2025
概括
一名接受伊克齐祖马布治疗牛皮的患者患有急性呼吸衰竭,肺部病变扩散. 这一案例突出显示了17型白蛋白抑制剂的潜在不良影响,需要进一步调查.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
背景情况:
- 牛皮是一种慢性自身免疫性疾病.
- 干白素-17 (IL-17) 抑制剂是适度至重症牛皮的有效治疗方法.
- 与IL-17抑制剂相关的肺部不良事件很少发生,但严重.
研究的目的:
- 在接受ixekizumab治疗的患者中报告急性呼吸衰竭病例.
- 调查IL-17抑制与肺病理之间的潜在联系.
主要方法:
- 一个55岁患有牛皮的女性的病例介绍.
- 临床评估包括胸部CT和动脉血液气体分析.
- 对患者病史和药物使用 (ixekizumab) 的审查.
主要成果:
- 患者出现了发烧,咳,呼吸障碍和低氧化症.
- 胸部CT显示了扩散的肺病变.
- 尽管接受了治疗,呼吸衰竭却迅速进展.
- 皮肤病变在ixekizumab治疗后得到改善.
结论:
- 伊克西祖马布治疗可能与严重的急性肺部并发症有关.
- 需要进一步的研究来了解IL-17抑制剂诱导的肺病的机制和发病率.
- 临床医生应考虑在出现呼吸道症状的患者中与IL-17抑制剂相关的肺毒性.
相关概念视频
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.5K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.5K
01:22Chronic Obstructive Pulmonary Disease
2.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.5K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.5K
01:20COPD: Pathogenesis and Clinical Features
1.7K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K
01:27Pneumothorax-II
852
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
852